COMMUNIQUÉS West-GlobeNewswire

Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Cream USP, 0.05%
17/04/2018
BUENA, N.J., April 17, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Marrone Bio Innovations, Inc. Announces Proposed Public Offering of Common Stock
17/04/2018
DAVIS, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) or ("the Company"), a leading provider of bio-based pest management and plant health products for the agriculture, turf and [...]
Retrophin to Report First Quarter 2018 Financial Results
17/04/2018
SAN DIEGO, April 17, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced it will report first quarter 2018 financial results on Tuesday, May 1, 2018 after the close of the U.S. financial markets. [...]
EyeGate Announces Completion of $11.25 Million Public Offering
17/04/2018
WALTHAM, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (Nasdaq: EYEG ) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing products [...]
Globus Medical Schedules First Quarter 2018 Earnings Release and Conference Call
17/04/2018
AUDUBON, Penn., April 17, 2018 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2018 after [...]
Medigus and HC Marbella International Hospital Announce First MUSE™ Procedure for GERD Treatment in Spain
17/04/2018
-Leading gastroenterologist reports successful procedure with comprehensive endoscopic device- OMER, Israel, and MARBELLA, Spain, April 17, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS ) (TASE: MDGS ), a medical [...]
Syneos Health Schedules First Quarter 2018 Earnings Call for Wednesday, May 9, 2018
17/04/2018
RALEIGH, N.C., April 17, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract Commercial Organization), will [...]
Intuitive Surgical Announces First Quarter Earnings
17/04/2018
SUNNYVALE, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (“Intuitive”) (Nasdaq: ISRG ), a global technology leader in robotic-assisted, minimally invasive surgery, today announced financial results [...]
GenMark Diagnostics Schedules First Quarter Financial Results Conference Call for May 1, 2018
17/04/2018
CARLSBAD, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK ) today announced that it plans to release its first quarter earnings results after market close on Tuesday, May 1, 2018. [...]
Novartis presents first-of-its-kind evidence at AAN reinforcing robust and consistent efficacy of AimovigTM* (erenumab) for migraine patients with multiple treatment failures
17/04/2018
The LIBERTY trial studied patients with episodic migraine who had failed 2 to 4 prior treatments, a uniquely difficult-to-treat population often excluded from migraine prevention trials Patients taking erenumab had [...]
Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock
17/04/2018
AUSTIN, Texas, April 17, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (Nasdaq: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]
Aduro Biotech Highlights Preclinical Data for Three Programs Reported at the American Association for Cancer Research Annual Meeting
17/04/2018
BERKELEY, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that data from three of the company’s programs were presented at the American Association for Cancer Research ( [...]
Nature's No. 1 Sustainably – strategy update
17/04/2018
Company announcement No. 08 / 2018 Attachment No 08 Natures no1 sustainably
INNATE PHARMA : Promising anti-tumor activity of monalizumab with cetuximab in SCCHN
17/04/2018
preliminary data suggest promising anti-tumor activity of the combination of monalizumab and cetuximab in patients with platinum pretreated SCCHN 8 partial responses (PR) among 26 patients evaluable for efficacy - [...]
INNATE PHARMA : Données préliminaires d'activité prometteuses pour la combinaison monalizumab et cetuximab dans le SCCHN
17/04/2018
DONNÉES PRÉLIMINAIRES D'ACTIVITÉ PROMETTEUSES POUR LA COMBINAISON DE MONALIZUMAB ET CETUXIMAB CHEZ DES PATIENTS ATTEINTS D'UN CANCER DE LA TÊTE ET DE COU ET PRÉTRAITÉS PAR SELS DE PLATINE Huit réponses partielles (PR) [...]
AACR annual meeting 2018: Nanobiotix presented preclinical data showing NBTXR3 nanoparticles can activate the cGAS-STING pathway
17/04/2018
AACR ANNUAL MEETING 2018: NANOBIOTIX PRESENTED PRECLINICAL DATA SHOWING NBTXR3 NANOPARTICLES CAN ACTIVATE THE cGAS-STING PATHWAY Paris, France and Cambridge, Massachusetts, April 17, 2018 - NANOBIOTIX (Euronext: NANO - [...]
AACR annual meeting 2018: Nanobiotix a presenté des données précliniques montrant que les nanoparticules NBTXR3 peuvent activer la voie cGAS-STING
17/04/2018
AACR ANNUAL MEETING 2018: NANOBIOTIX A PRESENTE DES DONNEES PRECLINIQUES MONTRANT QUE LES NANOPARTICULES NBTXR3 PEUVENT ACTIVER LA VOIE cGAS-STING Paris, France et Cambridge, Massachusetts, USA, 17 avril, 2018 - [...]
Aptose Presents Preclinical Data on APTO-253 at 2018 AACR Annual Meeting
17/04/2018
Cancer cells deficient in BRCA1 or BRCA2 function hyper-sensitive to APTO-253 CHICAGO and SAN DIEGO and TORONTO, April 17, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO ) (TSX: APS ) today announced the [...]
Durham College and GrowWise Health partner to develop Cannabis Industry Specialization certificate
17/04/2018
First-of-its-kind program will prepare business professionals to join Canada’s cannabis industry OSHAWA, Ontario, April 17, 2018 (GLOBE NEWSWIRE) -- Durham College (DC) and Emblem Corp. (TSXV:EMC) (EMC.WT) (Emblem), on [...]

Pages